Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Treatment Response to Rehabilitation in Patients With Schizophrenia
This study is currently recruiting participants.
Verified by National Institute of Mental Health (NIMH), November 2005
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00063336
  Purpose

This study will examine the ways in which schizophrenia-related symptoms affect response to a rehabilitation program for people with schizophrenia.


Condition
Schizophrenia

MedlinePlus related topics: Rehabilitation Schizophrenia
U.S. FDA Resources
Study Type: Observational
Study Design: Psychosocial, Longitudinal, Defined Population, Prospective Study
Official Title: Treatment Response to Rehabilitation in Schizophrenia

Further study details as provided by National Institute of Mental Health (NIMH):

Detailed Description:

Patients with schizophrenia often suffer neurocognitive impairment and psychosocial and vocational difficulties. This study will help identify those patients most likely to benefit from existing behavioral treatments and provide clues for how to modify treatments for those who do not benefit.

Two studies will be conducted. The first will investigate the relationship of symptoms and neurocognitive variables at study entry to psychosocial and vocational status 2 years later. The second study will investigate the relationship of symptoms and neurocognitive variables at study entry to treatment response in patients assigned to either a cognitive remediation track or a computer skills track as part of their rehabilitation treatment.

Both the cognitive remediation and computer skills training programs will last 4 to 6 months. Participants will be assessed pre- and post-treatment. Neuropsychological, psychosocial and vocational status will be measured.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM-IV criteria for schizophrenia or schizoaffective disorder
  • In need of intensive outpatient care
  • Treatment with atypical antipsychotic medication for a minimum of 6 months prior to study entry

Exclusion Criteria:

  • Auditory or visual impairment
  • Mental retardation (IQ < 70)
  • Traumatic brain injury with loss of consciousness
  • Presence or history of any neurological illness that may affect brain physiology
  • Lack of proficiency in English
  • Concurrent substance abuse and/or dependence
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00063336

Locations
United States, Connecticut
Schizophrenia Rehabilitation Program, Institutes of Living Recruiting
Hartford, Connecticut, United States, 06106
Contact: Matthew M. Kurtz, PhD     860-545-7304     mkurtz@harthosp.org    
Sponsors and Collaborators
  More Information

Study ID Numbers: R03 MH65377, DSIR AT-SP
Study First Received: June 25, 2003
Last Updated: November 17, 2005
ClinicalTrials.gov Identifier: NCT00063336  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on January 30, 2009